Unichem Laboratories share rises 8% on US FDA approval for Apremilast tablets

Unichem Laboratories share rises 8% on US FDA approval for Apremilast tablets
The pharma share touched an intraday high of Rs 329.25, rising 7.74% on BSE
BusinessToday.In | February 19, 2021 | Updated 17:12 IST
Unichem Labs share stands higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages.
Unichem Laboratories share price rose nearly 8 percent today after United States Food and Drug Administration's (US FDA)  awarded approval for its Apremilast tablets. The stock has gained 6.9% in the last 4 days. The pharma share touched an intraday high of Rs 329.25, rising 7.74% on BSE.
Unichem Labs share stands higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages. The share has gained 131.55% in one year and risen 22.66% since the beginning of this year. Later, the small cap stock closed 4.94% or Rs 15.10 higher at Rs 320.70.

Related Keywords

United States ,Amgen Otezla ,Drug Administration ,Unichem Laboratories ,United States Food ,Apremilast Tablets ,Gupta Equity Research Associate ,Angel Broking ,Unichem Laboratories Share Price ,Unichem Laboratories Share Rises ,Usfda ,ஒன்றுபட்டது மாநிலங்களில் ,ஒன்றுபட்டது மாநிலங்களில் உணவு ,குப்தா பங்கு ஆராய்ச்சி இணை ,தேவதை தரகு ,